(Q38218544)

English

Review article: the efficacy of biomarkers in chronic fibroproliferative diseases - early diagnosis and prognosis, with liver fibrosis as an exemplar.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24909260%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Review article: the efficacy of biomarkers in chronic fibroproliferative diseases - early diagnosis and prognosis, with liver fibrosis as an exemplar (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24909260%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

0 references

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24909260%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24909260%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24909260%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Ove B Schaffalitzky de Muckadell

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24909260%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Aleksander Krag

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24909260%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

author name string

M A Karsdal

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24909260%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

P B Christensen

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24909260%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

J Gerstoft

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24909260%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

D J Leeming

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24909260%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

language of work or name

0 references

publication date

9 June 2014

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24909260%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Alimentary Pharmacology & Therapeutics

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24909260%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

40

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24909260%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24909260%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

233-249

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24909260%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12820

21 January 2018

Welcome to fibrogenesis & tissue repair

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12820

21 January 2018

Macrophages: master regulators of inflammation and fibrosis

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12820

21 January 2018

Cellular and molecular mechanisms of fibrosis

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12820

21 January 2018

Matrix as a modulator of hepatic fibrogenesis

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12820

21 January 2018

Liver cirrhosis

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12820

21 January 2018

Evolving therapies for liver fibrosis

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12820

21 January 2018

Osteoarthritis--a case for personalized health care?

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12820

21 January 2018

Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12820

21 January 2018

Therapy for fibrotic diseases: nearing the starting line

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12820

21 January 2018

Macrophage activation governs schistosomiasis-induced inflammation and fibrosis

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12820

21 January 2018

IgG4-related disease

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12820

21 January 2018

Extracellular matrix and fibroblast communication following myocardial infarction

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12820

21 January 2018

Integrating mechanisms of pulmonary fibrosis

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12820

21 January 2018

Mechanisms of fibrosis: therapeutic translation for fibrotic disease

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12820

21 January 2018

Deactivation of hepatic stellate cells during liver fibrosis resolution in mice.

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12820

21 January 2018

Myofibroblasts revert to an inactive phenotype during regression of liver fibrosis

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12820

21 January 2018

Lower liver stiffness in patients with sustained virological response 4 years after treatment for chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12820

21 January 2018

Serum procollagen peptides and collagen type VI for the assessment of activity and degree of hepatic fibrosis in schistosomiasis and alcoholic liver disease

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12820

21 January 2018

Current status of novel antifibrotic therapies in patients with chronic liver disease

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12820

21 January 2018

Anti-fibrotic therapy: lost in translation?

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12820

21 January 2018

Protein fingerprinting of the extracellular matrix remodelling in a rat model of liver fibrosis--a serological evaluation.

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12820

21 January 2018

Novel serological neo-epitope markers of extracellular matrix proteins for the detection of portal hypertension.

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12820

21 January 2018

Biomarkers in COPD.

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12820

21 January 2018

Evaluation of liver fibrosis: a concise review

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12820

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12820

21 January 2018

Liver fibrosis -- from bench to bedside

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12820

21 January 2018

Reversal of hepatic fibrosis -- fact or fantasy?

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12820

21 January 2018

Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12820

21 January 2018

Non-alcoholic steatohepatitis: pathogenesis and novel therapeutic approaches.

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12820

21 January 2018

Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12820

21 January 2018

A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010.

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12820

21 January 2018

Global burden of alcoholic liver diseases

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12820

21 January 2018

Prospective evaluation of alcohol abuse and alcoholic liver injury in men as predictors of development of cirrhosis

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12820

21 January 2018

Prevalence and natural history of alcoholic liver disease

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12820

21 January 2018

Liver fibrosis progression at autopsy in injecting drug users infected by hepatitis C: a longitudinal long-term cohort study

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12820

21 January 2018

Validation of terminal peptide of procollagen III for the detection and assessment of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12820

21 January 2018

The clinical use of HVPG measurements in chronic liver disease

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12820

21 January 2018

Performance of transient elastography for the staging of liver fibrosis: a meta-analysis

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12820

21 January 2018

Liver stiffness is associated with risk of decompensation, liver cancer, and death in patients with chronic liver diseases: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12820

21 January 2018

Magnetic resonance elastography for the noninvasive staging of liver fibrosis.

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12820

21 January 2018

Serum markers of the extracellular matrix remodeling reflect antifibrotic therapy in bile-duct ligated rats.

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12820

21 January 2018

Identification of progressors in osteoarthritis by combining biochemical and MRI-based markers

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12820

21 January 2018

Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12820

21 January 2018

Meta-analysis: ARFI elastography versus transient elastography for the evaluation of liver fibrosis.

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12820

21 January 2018

Serum markers detect the presence of liver fibrosis: a cohort study.

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12820

21 January 2018

Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12820

21 January 2018

A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12820

21 January 2018

Novel combinations of Post-Translational Modification (PTM) neo-epitopes provide tissue-specific biochemical markers--are they the cause or the consequence of the disease?

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12820

21 January 2018

Collagens—structure, function, and biosynthesis

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12820

21 January 2018

Structure of the extracellular matrix in normal and fibrotic liver: collagens and glycoproteins

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12820

21 January 2018

Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-beta as major players and therapeutic targets

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12820

21 January 2018

Quantification of "end products" of tissue destruction in inflammation may reflect convergence of cytokine and signaling pathways -- implications for modern clinical chemistry

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12820

21 January 2018

Procollagen type I N-terminal propeptide (PINP) is a marker for fibrogenesis in bile duct ligation-induced fibrosis in rats

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12820

21 January 2018

Serum concentrations of formation (PINP) and resorption (Ctx) bone turnover markers in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12820

21 January 2018

Serum concentration of the cross-linked carboxyterminal telopeptide of type I collagen (ICTP) is a useful prognostic indicator in multiple myeloma

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12820

21 January 2018

Purification and characterization of the N-terminal propeptide of human type III procollagen

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12820

21 January 2018

TIMP-3 inhibits the procollagen N-proteinase ADAMTS-2.

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12820

21 January 2018

A novel assay for extracellular matrix remodeling associated with liver fibrosis: An enzyme-linked immunosorbent assay (ELISA) for a MMP-9 proteolytically revealed neo-epitope of type III collagen

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12820

21 January 2018

Circulating protein fragments of cartilage and connective tissue degradation are diagnostic and prognostic markers of rheumatoid arthritis and ankylosing spondylitis

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12820

21 January 2018

Measurement of matrix metalloproteinase 9-mediated collagen type III degradation fragment as a marker of skin fibrosis

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12820

21 January 2018

Matrix metalloproteinase-9-mediated type III collagen degradation as a novel serological biochemical marker for liver fibrogenesis

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12820

21 January 2018

Assessment of proteolytic degradation of the basement membrane: a fragment of type IV collagen as a biochemical marker for liver fibrosis

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12820

21 January 2018

MMP mediated type V collagen degradation (C5M) is elevated in ankylosing spondylitis.

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12820

21 January 2018

MMP mediated degradation of type VI collagen is highly associated with liver fibrosis--identification and validation of a novel biochemical marker assay

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12820

21 January 2018

Enzyme-linked immunosorbent serum assays (ELISAs) for rat and human N-terminal pro-peptide of collagen type I (PINP)--assessment of corresponding epitopes

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12820

21 January 2018

Serum levels of type IIA procollagen amino terminal propeptide (PIIANP) are decreased in patients with knee osteoarthritis and rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12820

21 January 2018

Immunological detection of the type V collagen propeptide fragment, PVCP-1230, in connective tissue remodeling associated with liver fibrosis

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12820

21 January 2018

Macrophage-mediated proteolytic remodeling of the extracellular matrix in atherosclerosis results in neoepitopes: a potential new class of biochemical markers

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12820

21 January 2018

Biglycan fragmentation in pathologies associated with extracellular matrix remodeling by matrix metalloproteinases

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12820

21 January 2018

Levels of Circulating MMCN-151, a Degradation Product of Mimecan, Reflect Pathological Extracellular Matrix Remodeling in Apolipoprotein E Knockout Mice

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12820

21 January 2018

Clinical evaluation of a matrix metalloproteinase-12 cleaved fragment of titin as a cardiovascular serological biomarker.

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12820

21 January 2018

Cartilage degradation is fully reversible in the presence of aggrecanase but not matrix metalloproteinase activity

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12820

21 January 2018

The type I collagen fragments ICTP and CTX reveal distinct enzymatic pathways of bone collagen degradation.

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12820

21 January 2018

In vitro, ex vivo, and in vivo methodological approaches for studying therapeutic targets of osteoporosis and degenerative joint diseases: how biomarkers can assist?

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12820

21 January 2018

Serum CrossLaps for monitoring the response in individuals undergoing antiresorptive therapy.

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12820

21 January 2018

Circadian variation in the serum concentration of C-terminal telopeptide of type I collagen (serum CTx): effects of gender, age, menopausal status, posture, daylight, serum cortisol, and fasting

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12820

21 January 2018

Increased urinary excretion of C-telopeptides of type II collagen (CTX-II) predicts cartilage loss over 21 months by MRI.

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12820

21 January 2018

Aα-Val360: a marker of neutrophil elastase and COPD disease activity

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12820

21 January 2018

The fibrinogen cleavage product Aα-Val360, a specific marker of neutrophil elastase activity in vivo

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12820

21 January 2018

Increased type II collagen cleavage by cathepsin K and collagenase activities with aging and osteoarthritis in human articular cartilage

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12820

21 January 2018

M30 neoepitope expression in epithelial cancer: quantification of apoptosis in circulating tumor cells by CellSearch analysis.

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12820

21 January 2018

Ectodomain shedding generates Neoepitopes on collagen XVII, the major autoantigen for bullous pemphigoid.

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12820

21 January 2018

Extracellular matrix remodeling: the common denominator in connective tissue diseases. Possibilities for evaluation and current understanding of the matrix as more than a passive architecture, but a key player in tissue failure

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12820

21 January 2018

Classification of osteoarthritis biomarkers: a proposed approach.

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12820

21 January 2018

Value of biomarkers in osteoarthritis: current status and perspectives.

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12820

21 January 2018

Biochemical markers and the FDA Critical Path: how biomarkers may contribute to the understanding of pathophysiology and provide unique and necessary tools for drug development

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12820

21 January 2018

Serological identification of fast progressors of structural damage with rheumatoid arthritis.

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12820

21 January 2018

Influence of food intake on the bioavailability and efficacy of oral calcitonin

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12820

21 January 2018

Investigation of the diurnal variation in bone resorption for optimal drug delivery and efficacy in osteoporosis with oral calcitonin

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12820

21 January 2018

Diurnal variation of serum and urine biomarkers in patients with radiographic knee osteoarthritis

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12820

21 January 2018

Application of a new serum assay for type I collagen cross-linked N-telopeptides: assessment of diurnal changes in bone turnover with and without alendronate treatment

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12820

21 January 2018

Variation in osteoarthritis biomarkers from activity not food consumption

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12820

21 January 2018

Biochemical markers of ongoing joint damage in rheumatoid arthritis--current and future applications, limitations and opportunities

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12820

21 January 2018

Accuracy of real-time shear wave elastography for assessing liver fibrosis in chronic hepatitis C: A pilot study

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12820

21 January 2018

Development of an immunoassay for the derived-peptide of chromogranin A, Vasostatin-I (1-76): assessment of severity in patients with sepsis

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12820

21 January 2018

Vasostatin-I, a chromogranin A-derived peptide, in non-selected critically ill patients: distribution, kinetics, and prognostic significance

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12820

21 January 2018

Reduced Mortality Rates Following Elective Percutaneous Liver Biopsies

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12820

21 January 2018

Evaluation of serum CC-16 as a biomarker for COPD in the ECLIPSE cohort

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12820

21 January 2018

Low liver stiffness among cirrhotic patients with hepatitis B after prolonged treatment with nucleoside analogs

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12820

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38218544&oldid=1510337523"